FRANK HURLEY AND CATHARINE DORRIER PROFESSORSHIP AND CHAIR IN BIOSTATISTICS
Established in 2005, with a commitment made in 2000 from Frank Hurley and Catharine Dorrier

Image Credit: Michael & Kathy Day/Image Preservation Company FRANK HURLEY, SPH 1971 (PhD), and his wife and colleague, CATHARINE DORRIER, have dedicated their careers to bringing safe and effective health care products to people around the world. Dr. Hurley is chairman and chief scientific officer of RRD International, a health care product development company which he co-founded in 2002. Dr. Hurley was also co-founder in 1971 of Biometric Research Institute, later BRI International, and served as chief scientific officer of Quintiles Transnational Corporation when BRI and Quintiles merged in 1996. Ms. Dorrier joined BRI in 1973, served as a senior technical advisor at Quintiles, and is currently a senior technical advisor at RRD International.

The two biostatisticians have been involved in trials of over 100 medical products, working with federal agencies, pharmaceutical, medical device, and biotechnology companies. They contributed to numerous product approvals by the Food and Drug Administration, including the first bioengineered human growth hormone; drugs for treatment of cancer, cardiovascular disease, and arthritis; as well as diagnostic (MRI, ultrasound, monoclonal antibodies) and therapeutic (cardiovascular, ophthalmic, orthopedic) medical devices.

Their support of biostatistics reflects the couple's belief that the key to improving international public health is turning data into information, and information into useful knowledge. Ms. Dorrier is a member of the Bloomberg School's Health Advisory Board. In addition to their support of Hopkins, Dr. Hurley and Ms. Dorrier, through the BRI Foundation, support a variety of educational and recreational organizations, particularly focusing on children and young adults.

 

KAREN BANDEEN-ROCHE, the Frank Hurley and Catharine Dorrier Professor, joined the Johns Hopkins Bloomberg School of Public Health in 1990, rising to the rank of professor in 2002. She served as co-director of the Epidemiology and Biostatistics of Aging Training Program from 1996 until April 2008 when she became its director. She received the Bloomberg School’s Advising, Mentoring and Teaching Recognition Award in 2001 and 2005. She is the first woman to lead the Department of Biostatistics. Dr. Bandeen-Roche is a fellow of the American Statistical Association (ASA), a 1997 Brookdale National Fellow, and served as chair of the ASA Biometrics Section in 2006 and as chair of the Biostatistical Methodology and Research Design Study Section of the National Institutes of Health from 2006 to 2008. Her disciplinary research is primarily focused on latent variable modeling. Her collaborative research has been primarily on aging, ophthalmology, and neurology and has contributed to advancing knowledge on disability, frailty, and visual functioning in older adults and the ramifications of adverse environmental exposures for cognitive health. She is president of the International Biometrics Society/Eastern North American Region, 2012 (Executive Committee 2011-2013).